SCHEMBL9004616

SCHEMBL9004616

Cc1cccc(Cl)c1NC(=O)NN=c1c(=O)c2ccccc2c1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.46
SENP6 Q9GZR1 3/20 0.46
KMT2A Q03164 3/20 0.46
CASP3 P42574 2/20 0.46
SENP8 Q96LD8 2/20 0.46
SENP7 Q9BQF6 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
MEN1 O00255 2/20 0.46
APAF1 O14727 1/20 0.46
TDP2 O95551 1/20 0.46
ALDH1A1 P00352 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
THRB P10828 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
LMNA P02545 1/20 0.46
PDK1 Q15118 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9004618 0.80 KMT2A (0.63) MAPTSENP6KMT2ACASP3SENP8
SCHEMBL9004650 0.80 MAPT (0.51) MAPTSENP6KMT2ACASP3SENP8
SCHEMBL9004777 0.77 KMT2A (0.51) MAPTSENP6KMT2ACASP3SENP8
SCHEMBL9004678 0.74 SMN1; SMN2 (0.51) MAPTSENP6KMT2ACASP3SENP8
SCHEMBL9004631 0.74 SMN1; SMN2 (0.51) MAPTSENP6KMT2ACASP3SENP8
SCHEMBL9004666 0.74 KMT2A (0.52) MAPTSENP6KMT2ACASP3SENP8
SCHEMBL8667830 0.73 SENP6 (0.61) MAPTSENP6KMT2ACASP3SENP8
Water SCHEMBL9571731 0.73 KMT2A (0.51) MAPTSENP6KMT2ACASP3SENP8
SCHEMBL9004699 0.73 HTT (0.48) MAPTSENP6KMT2ACASP3SENP8
SCHEMBL8421171 0.71 PDK1 (0.54) ALDH1A1PDK1PDK2PDK3PDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5571843-A Derivatives of indan-1,3-dione and indan-1,2,3-trione, methods of preparing them and therapeutic use thereof INNOTHERA (FR) 1996-11-05 US disclosed
EP-0566445-B1 Derivatives of indane 1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy INNOTHERA LAB SA (FR) 1996-02-07 EP disclosed
EP-0566445-A1 Derivatives of indane 1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy INNOTHERA (FR) 1993-10-20 EP disclosed
WO-1993020045-A1 INDAN-1,3-DIONE AND INDAN-1,2,3-TRIONE DERIVATIVES, PROCESSES FOR THE PREPARATION OF SAME AND THEIR APPLICATION AS THERAPEUTIC AGENTS INNOTHERA (FR) 1993-10-14 WO disclosed